Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

The requested reference [6f101d7e74dd756abfe31c52bfda3a93521c75f6] no longer exists in our database. It has been replaced by the current reference: [118a2be01149c07c62366755f4350b8105a3c8bc]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The study is designed to evaluate safety and efficacy of PP405 in adult female participants with androgenetic alopecia
Epistemonikos ID: 39b464c87766c8568964bed90b9c5b4c009d1970
First added on: Oct 31, 2026